您的位置: 首页 > 农业专利 > 详情页

MULTI-LEVEL SPECIFIC TARGETING OF CANCER CELLS
专利权人:
Wake Forest University Health Sciences
发明人:
Waldemar Debinski,Hetal Pandya,Denise Gibo
申请号:
US16704645
公开号:
US20200095302A1
申请日:
2019.12.05
申请国别(地区):
US
年份:
2020
代理人:
摘要:
A compound comprising, in combination: a cell surface binding ligand or internalizing factor, such as an IL-13Rα2 binding ligand; at least one effector molecule (e.g., one, two, three or more effector molecules); optionally but preferably, a cytosol localization element covalently coupled between said binding ligand and said at least one effector molecule; and a subcellular compartment localization signal element covalently coupled between said binding ligand and said at least one effector molecule (and preferably with said cytosol localization element between said binding ligand and said subcellular compartment localization signal element). Methods of using such compounds and formulations containing the same are also described.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充